Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results.

Cancer medicine·2025
Same author

Hormone sensitive protocol for metastatic prostate cancer, an update.

Actas urologicas espanolas·2022
Same author

Usefulness of neoadjuvant chemotherapy in non-metastatic muscle-invasive bladder cancer.

Actas urologicas espanolas·2021
Same author

Liquid biopsy in cancer.

Actas urologicas espanolas·2015
Same author

[Not Available].

Semergen·2015
Same author

[Detection and diagnosis of the premature ejaculation in the clinical practice].

Semergen·2015

Related Experiment Video

Updated: Jul 25, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

p53 Gene mutations in superficial bladder cancer.

J G Lorenzo Romero1, A S Salinas Sánchez, J M Giménez Bachs

  • 1Servicio de Urología, Complejo Hospitalario y Universitario de Albacete, Albacete, España. juangabriello@terra.es

Urologia Internationalis
|November 13, 2004
PubMed
Summary

p53 gene mutations are common in superficial bladder cancer, particularly in higher-grade tumors. These mutations affect the P53 protein structure and may offer prognostic value for bladder transitional cell carcinoma.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Experiment Videos

Last Updated: Jul 25, 2026

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Superficial bladder tumors, specifically transitional cell carcinoma (TCC), present a risk for recurrence and progression.
  • The p53 tumor suppressor gene plays a critical role in cell cycle regulation and apoptosis.
  • Understanding p53 gene mutations in TCC is crucial for assessing cancer prognosis.

Purpose of the Study:

  • To investigate the prevalence of p53 gene mutations in superficial TCC.
  • To determine the association between p53 mutations and established prognostic factors for bladder cancer.
  • To analyze the impact of these mutations on P53 protein structure and function.

Main Methods:

  • An observational, cross-sectional study involving 90 patients (60 with superficial TCC, 30 controls).
  • Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) was used to detect p53 mutations in exons 5-9.
  • Automatic sequencing identified mutation characteristics and their effects on P53 protein structure, with bivariate analysis for prognostic factors.

Main Results:

  • No p53 mutations were found in the control group; 38.3% of superficial TCC patients exhibited mutations.
  • All detected mutations were point mutations, with 86.67% impacting P53 structure, often in conserved regions or mutational hotspots.
  • Higher cell differentiation grades and pT1 stage were linked to increased p53 mutation incidence.

Conclusions:

  • p53 gene mutations are absent in healthy bladder mucosa and significantly more prevalent in high-grade (G-II/G-III) and pT1 stage superficial TCC.
  • The majority of detected point mutations caused substantial P53 structural abnormalities, likely affecting its function.
  • While not linked to all classic prognostic factors, specific p53 mutations may hold prognostic significance in superficial bladder cancer, warranting further investigation.